The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Open accessAbstract
Objectives This was a retrospective analysis to determine the effect of diabetes on outcome in patients with advanced heart failure (HF), and to determine the effect of beta-blockade in patients with HF with and without diabetes mellitus.Background In chronic HF the impact on clinical outcomes and therapeutic response of the prevalent comorbid condition diabetes mellitus has not been extensively investigated.Methods We assessed the impact of diabetes on prognosis and effectiveness of beta-blocker therapy with bucindolol in patients with HF enrolled in the Beta-Blocker Evaluation of Survival Trial (BEST). We conducted a retrospective analysis to examine the prognosis of patients with advanced HF with and without diabetes, and the effect of beta-blocker therapy on mortality and HF progression or myocardial infarction (MI). The database was the 2,708 patients with advanced HF (36% with diabetes and 64% without diabetes) who were randomized to the beta-blocker bucindolol or placebo in BEST and followed for mortality, hospitalization, and MI for an average of two years.Results Patients with diabetes had more severe chronic HF and more coronary risk factors than patients without diabetes. Diabetes was independently associated with increased mortality in patients with ischemic cardiomyopathy (adjusted hazard ratio 1.33, 95% confidence interval 1.12 to 1.58, p = 0.001), but not in those with a nonischemic etiology (adjusted hazard ratio 0.98, 95% confidence interval 0.74 to 1.30, p = 0.89). Compared with patients without diabetes, in diabetic patients beta-blocker therapy was at least as effective in reducing death or HF hospitalizations, total hospitalizations, HF hospitalizations, and MI. Ventricular function and physiologic responses to beta-blockade were similar in patients with and without diabetes.Conclusions Diabetes worsens prognosis in patients with advanced HF, but this worsening appears to be limited to patients with ischemic cardiomyopathy. In advanced HF beta-blockade is effective in reducing major clinical end points in patients with and without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with placebo, empagliflozin reduced the risk of the primary outcome, a composite of CV death or hospitalization for HF, by 21%, which was mainly related to a 29% lower risk of hospitalization for HF.530”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [530]
In the citing paper
“In three early clinical trials (SOLVD, 98 BEST, 94 and DIG 102 )t h er i s k appeared to be confined to those with an ischaemic aetiology.”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [94]
In the citing paper
“The majority of the available data suggests that T2DM is associated with higher risk of mortality in both patients of ischaemic and non-ischaemic aetiology (Table 6).29,88,94,96 -99”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [94]
In the citing paper
“In the BEST trial, T2DM was an independent risk factor for death from pump failure.94”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Lechat, P. P., Brunhuber, K., Hofmann, R., Kuhn, P., Nesser, H., Slany, J., Weihs, W., Wiedermann, C. J., Wimmer, H., van Mieghem, W., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,922
Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K. L., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. A. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,865
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,440
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Research works printed but not linked: 4
- Schaffer, 1989, Basis for mechanical defects associated with non-insulin-dependent diabetes, Am J Physiol, 256, E25
- Domanski, 2001, A comparative analysis of the results of three trials of beta-blocker therapy for heart failure, J Cardiac Failure, 7, 56
- Sederberg, 2000, Bucindolol has no sympathomimetic activity in nonfailing ventricular preparations, J Am Coll Cardiol, 35, 207A
- Bristow, 1996, Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or nonischemic dilated cardiomyopathy, Circulation, 94, I664
Cited by
Sorted by citations
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock, S., Wang, D., Pfeffer, M. A., Yusuf, S., McMurray, J. J. V., Swedberg, K. B., Östergren, J., Michelson, E. L., Pieper, K. S., & Granger, C. B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi555 · Cited by 972
Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis
Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015) · JAMA · doi:10.1001/jama.2014.18574 · Cited by 854
MacDonald, M. R., Petrie, M. C., Varyani, F., Ostergren, J., Michelson, E. L., Young, J. B., Solomon, S. D., Granger, C. B., Swedberg, K., Yusuf, S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn153 · Cited by 694
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 556
Bozkurt, B., Aguilar, D. A., Deswal, A. M., Dunbar, S. B., Francis, G. S., Horwich, T. B., Jessup, M. L., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 556
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
Dei Cas, A., Khan, S. S., Butler, J., Mentz, R. J., Bonow, R. O., Avogaro, A., Tschoepe, D., Doehner, W., Greene, S. J., Senni, M., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.08.004 · Cited by 401
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
Hayat, S. A., Patel, B., Khattar, R. S., & Malik, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 353
Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction
Michel Komajda, N., Carson, P. E., Hetzel, S., McKelvie, R. S., McMurray, J. J. V., Ptaszynska, A., Zile, M. R., DeMets, D. L., & Massie, B. M. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.932996 · Cited by 254
pre-diabetes Task Force on diabetes (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 239
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., & McMurray, J. J. V. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn156 · Cited by 227
Sarma, S., Mentz, R. J., Kwasny, M. J., Fought, A. J., Huffman, M., Subacius, H., Nodari, S., Konstam, M., Swedberg, K., Maggioni, A. P., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs153 · Cited by 202
Smooke, S., Horwich, T. B., & Fonarow, G. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.005 · Cited by 196
Greenberg, B. H., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O'Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.001 · Cited by 196
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure
de Groote, P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.010 · Cited by 192
Beta-glucans in the treatment of diabetes and associated cardiovascular risks
Chen, J. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3803 · Cited by 186
Treatment of Chronic Heart Failure With β-Adrenergic Receptor Antagonists
Bristow, M. R. (2011) · Circulation Research · doi:10.1161/circresaha.111.245092 · Cited by 173
Self-citationYue, T.-L., Bao, W., Gu, J.-L., Cui, J., Tao, L., Ma, X.-L., Ohlstein, E. H., & Jucker, B. M. (2005) · Diabetes · doi:10.2337/diabetes.54.2.554 · Cited by 170
Andersson, C., Olesen, J. B., Hansen, P. R., Weeke, P. E., Norgaard, M. L., Jørgensen, C. H., Lange, T., Abildstrom, S. Z., Schramm, T. K., Vaag, A. A., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1906-6 · Cited by 153
Suematsu, Y., Miura, S., Goto, M., Matsuo, Y., Arimura, T., Kuwano, T., Imaizumi, S., Iwata, A., Yahiro, E., & Saku, K. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.474 · Cited by 156
Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction
Frazier‐Mills, C. G., Alexander, K. P., Newby, L. K., Anderson, S., Iverson, E. R., Packer, M., Cohn, J. N., Goldstein, S., & Douglas, P. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.041 · Cited by 152
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.008 · Cited by 145
Dauriz, M., Targher, G., Laroche, C., Temporelli, P. L., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M., Mebazaa, A., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2016 · Cited by 139
Barlera, S., Tavazzi, L., Franzosi, M. G., Marchioli, R., Raimondi, E., Masson, S., Urso, R., Lucci, D., Nicolosi, G. L., Maggioni, A. P., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967828 · Cited by 129
Galbut, D. L., Kurlansky, P. A., Traad, E. A., Dorman, M. J., Zucker, M., & Ebra, G. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.12.026 · Cited by 128
Dauriz, M., Mantovani, A., Bonapace, S., Verlato, G., Zoppini, G., Bonora, E., & Targher, G. (2017) · Diabetes Care · doi:10.2337/dc17-0697 · Cited by 123
Lee, M. M. Y., McMurray, J. J. V., Lorenzo-Almorós, A., Kristensen, S. L., Sattar, N. A., Jhund, P. S., & Petrie, M. C. (2018) · Heart · doi:10.1136/heartjnl-2016-310342 · Cited by 121
The Real Role of β-Blockers in Daily Cardiovascular Therapy
Dézsi, C. A., & Szentes, V. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0221-8 · Cited by 117
Arnold, J. M. O., Howlett, J. G., Ducharme, A., Ezekowitz, J. A., Gardner, M. J., Giannetti, N., Haddad, H. A., Heckman, G. A., Isaac, D., Jong, P., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70545-2 · Cited by 103
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
Johansson, I., Dahlström, U., Edner, M., Näsman, P., Rydén, L., & Norhammar, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.061 · Cited by 100
Adamopoulos, C., Meyer, P., Desai, R. V., Karatzidou, K., Ovalle, F., White, M., Aban, I., Love, T. E., DEEDWANIA, P. C., Anker, S. D., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq159 · Cited by 99
Self-citationHeart Failure and Diabetes Mellitus: Epidemiology and Management of an Alarming Association
Solal, A. C., Beauvais, F., & Logeart, D. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.04.001 · Cited by 94
Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy
Peterson, L. R., & Gropler, R. J. (2020) · Circulation Research · doi:10.1161/circresaha.120.315899 · Cited by 93
Concomitant Diabetes Mellitus and Heart Failure
Dei, A., Fonarow, G. C., Gheorghiade, M., & Butler, J. (2014) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2014.09.002 · Cited by 92
Diabetes Mellitus and Heart Failure: Epidemiology, Mechanisms, and Pharmacotherapy
Masoudi, F. A., & Inzucchi, S. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.013 · Cited by 89
Bristow, M. R., Krause-Steinrauf, H. J., Nuzzo, R., Liang, C., Lindenfeld, J. M., Lowes, B. D., Hattler, B. G. J., Abraham, W. T., Olson, L., Krueger, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000141297.50027.a4 · Cited by 87
Self-citationCai, L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.06.007 · Cited by 99
Shishido, T., Woo, C.-H., Ding, B., McClain, C., Molina, C. A. F., Chen, Y., Yang, J., & Abe, J. (2008) · Circulation Research · doi:10.1161/circresaha.107.168138 · Cited by 80
Komajda, M., Tavazzi, L., Francq, B. G., Böhm, M., Borer, J. S., Ford, I., & Swedberg, K. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.347 · Cited by 76
Diabetic cardiomyopathy – a distinct disease?
Khavandi, K., Khavandi, A., Asghar, O., Greenstein, A. S., Withers, S., Heagerty, A. M., & Malik, R. A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.016 · Cited by 72
Tribouilloy, C. M., Ruşinaru, D., Mahjoub, H., Tartiere, J.-H., Tartière-Kesri, L., Godard, S., & Peltier, M. (2008) · Heart · doi:10.1136/hrt.2007.128769 · Cited by 71
Dauriz, M., Targher, G., Temporelli, P. L., Lucci, D., Gonzini, L., Nicolosi, G. L., Marchioli, R., Tognoni, G., Latini, R., Cosmi, F., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005156 · Cited by 70
Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study
Varela-Roman, A., Shamagian, L. G., Caballero, E. B., Ramos, P. M., Veloso, P. R., & Gonzalez-Juanatey, J. R. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.017 · Cited by 69
Rushton, C. A., Satchithananda, D. K., Jones, P. W., & Kadam, U. T. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.180 · Cited by 69
Das, S. R., Drazner, M. H., Yancy, C. W., Stevenson, L. W., Gersh, B. J., & Dries, D. L. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.019 · Cited by 68
Animal models of insulin resistance and heart failure
Velez, M., Kohli, S., & Sabbah, H. N. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9387-6 · Cited by 66
Hirst, J. A., Farmer, A. A., Feakins, B. G., Aronson, J. K., & Stevens, R. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12543 · Cited by 64
Kodama*, S., Fujihara, K., Horikawa, C., Sato, T., Iwanaga, M., Yamada, T., Kato, K., Watanabe, K., Shimano, H., Izumi, T., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12782 · Cited by 63
Binkley, P. F., Lesinski, A., Ferguson, J. P., Hatton, P. S., Yamokoski, L. M., Hardikar, S. S., Cooke, G. E., & Leier, C. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.08.010 · Cited by 63
Carrasco-Sánchez, F. J., Gómez-Huelgas, R., Formiga, F., Martel, A. C., Trullàs, J. C., Bettencourt, P., Arévalo‐Lorido, J. C., & Montero-Pérez-Barquero, M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.015 · Cited by 64
Prevalence and Prognostic Implications of Pre-Diabetic State in Patients With Heart Failure
Matsue, Y., Suzuki, M., Nakamura, R. A., Abe, M., Ono, M., Yoshida, S., Seya, M., Iwatsuka, R., Mizukami, A., Setoguchi, M., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0754 · Cited by 61
CHOP deficiency prevents methylglyoxal-induced myocyte apoptosis and cardiac dysfunction
Nam, D.-H., Han, J.-H., Lee, T.-J., Shishido, T., Lim, J. H., Kim, G.-Y., & Woo, C.-H. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.05.016 · Cited by 61
Parissis, J. T., Rafouli-Stergiou, P., Mebazaa, A., Ikonomidis, I., Bistola, V., Nikolaou, M., Meas, T., Delgado, J., Vilas-Boas, F., Paraskevaidis, I., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.098 · Cited by 58
Type 2 diabetes mellitus: a cardiovascular perspective
Varughese, G. I., Tomson, J., & Lip, G. Y. H. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00571.x · Cited by 57
Ahmed, A., Aban, I. B., Vaccarino, V., Lloyd‐Jones, D. M., Goff, D. C., Zhao, J., Love, T. E., Ritchie, C., Ovalle, F., Gambassi, G., et al. (2007) · Heart · doi:10.1136/hrt.2006.113522 · Cited by 54
Johansson, I., Edner, M., Dahlström, U., Näsman, P., Rydén, L., & Norhammar, A. (2013) · European Journal of Heart Failure · doi:10.1002/ejhf.44 · Cited by 52
Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction
Nardi, P., Pellegrino, A., Scafuri, A., Colella, D., Bassano, C., Polisca, P., & Chiariello, L. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.02.062 · Cited by 52
Ghali, J. K., Boehmer, J., Feldman, A. M., Saxon, L. A., Demarco, T., Carson, P., Yong, P., Galle, E. G., Leigh, J., Ecklund, F. L., et al. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.06.723 · Cited by 50
Self-citationDunbar, S. B., Butts, B., Reilly, C. M., GARY, R. A., Higgins, M. K., Ferranti, E. P., Culler, S. D., & Butler, J. (2013) · Nursing Outlook · doi:10.1016/j.outlook.2013.09.003 · Cited by 48
Long-Term Outcome in Diabetic Heart Failure Patients Treated with Cardiac Resynchronization Therapy
Fantoni, C., Regoli, F. D., Ghanem, A., Raffa, S., Klersy, C., Sorgente, A., Faletra, F. F., Baravelli, M., Inglese, L., Salerno‐Uriarte, J. A., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.01.006 · Cited by 49
Bogner, H. R., Miller, S. D., de Vries, H. F., Chhatre, S., & Jayadevappa, R. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.01.007 · Cited by 45
Hoppe, U. C., Freemantle, N., Cleland, J. G. F., Marijianowski, M., & Erdmann, E. (2007) · Diabetes Care · doi:10.2337/dc06-2035 · Cited by 43
Mamas, M. A., Deaton, C., Rutter, M. K., Yuille, M., Williams, S. G., Ray, S. G., New, J. P., Gibson, M., & Neyses, L. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.027 · Cited by 42
New-onset Atrial Fibrillation Predicts Heart Failure Progression
Aleong, R. G., Sauer, W. H., Davis, G. W., & Bristow, M. R. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.06.006 · Cited by 42
Self-citationImpact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices
Asleh, R., Briasoulis, Α., Schettle, S. D., Tchantchaleishvili, V., Pereira, N. L., Edwards, B. S., Clavell, A. L., Maltais, S., Joyce, D. L., Joyce, L. D., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004213 · Cited by 41
de Boer, R. A., Doehner, W., van der Horst, I. C. C., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J., Flather, M. D., & van Veldhuisen, D. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.02.018 · Cited by 39
Velez, M., Peterson, E. L., Wells, K. E., Swadia, T. V., Sabbah, H. N., Williams, L. K., & Lanfear, D. E. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.10.012 · Cited by 40
Vest, A. R., Mistak, S. M., Hachamovitch, R., Mountis, M., Moazami, N., & Young, J. B. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.02.010 · Cited by 40
Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
Wilkinson, M. J., Zadourian, A., & Taub, P. R. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.024 · Cited by 40
Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
Tromp, J., Voors, A. A., Sharma, A., Ferreira, J. P., Ouwerkerk, W., Hillege, H. L., Gomez, K. F. A., Dickstein, K., Anker, S. D., Metra, M., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.11.005 · Cited by 39
Risk factors for mortality and hospital re-admission after surgical ventricular restoration
Sartipy, U., Albåge, A., & Lindblom, D. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.08.020 · Cited by 38
Nasir, S., & Aguilar, D. A. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.031 · Cited by 39
Karnik, A. A., Fields, A. V., & Shannon, R. P. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0086-3 · Cited by 37
Pavlovic, A. S., Polovina, M. M., Ristić, A. D., Seferović, J. P., Veljić, I., Simeunović, D. S., Milinković, I., Krljanać, G., Ašanin, M., Ostric, I., et al. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318807767 · Cited by 36
Kamalesh, M., & Cleophas, T. J. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.006 · Cited by 36
Type 2 Diabetes Mellitus and Heart Failure
Choy, C. K., Rodgers, J. E., Nappi, J. M., & Haines, S. T. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.170 · Cited by 34
Decreased Survival in Diabetic Patients with Heart Failure Due to Systolic Dysfunction
Kamalesh, M., Subramanian, U., Sawada, S. G., Eckert, G. J., Temkit, M., & Tierney, W. M. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.005 · Cited by 34
Heart Failure in Diabetes and Related Conditions
Kamalesh, M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.007 · Cited by 32
Cooper, L. B., Yap, J. J. L., Tay, W. T., Teng, T. K., MacDonald, M. R., Anand, I. S., Sharma, A., O’Connor, C. M., Kraus, W. E., Mentz, R. J., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1223 · Cited by 31
Pharmacological interventions for heart failure in people with chronic kidney disease
Lunney, M., Ruospo, M., Natale, P., Quinn, R. R., Ronksley, P. E., Konstantinidis, I., Palmer, S. C., Tonelli, M. A., Strippoli, G. F., & Ravani, P. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012466.pub2 · Cited by 33
Recent advances in metabolic imaging
Gropler, R. J. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9786-z · Cited by 28
Ahmed, A., Aronow, W. S., & Fleg, J. L. (2006) · American Journal of Therapeutics · doi:10.1097/00045391-200607000-00009 · Cited by 29
Romero, S. P., Garcia-Egido, A. A., Escobar, M. A., Andrey, J. L., Corzo, R., Perez, V., Garcia-Domiguez, G. J., & Gomez, F. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.134 · Cited by 29
Diabetic Cardiovascular Disease: Getting to the Heart of the Matter
Peterson, L. R., McKenzie, C. R., & Schaffer, J. E. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9374-7 · Cited by 29
Heart Failure—The Importance of Ethnicity
Sosin, M. D., Bhatia, G. S., Davis, R., & Lip, G. Y. H. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.11.019 · Cited by 28
Issa, V. S., Amaral, A. F., Cruz, F., Ayub‐Ferreira, S. M., Guimarães, G. V., Chizzola, P. R., Souza, G. E. C., & Bocchi, E. A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.027 · Cited by 27
Glucose Metabolism Abnormalities in Heart Failure Patients
Marsico, F., Gargiulo, P., Marra, A. M., Parente, A., & Paolillo, S. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.02.002 · Cited by 29
Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure
Kapoor, J. R., Fonarow, G. C., Zhao, X., Kapoor, R., Hernandez, A. F., & Heidenreich, P. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.008 · Cited by 26
Egom, E. E. A., Mamas, M. A., & Clark, A. L. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.699043 · Cited by 26
Shin, S., Claggett, B. L., Pfeffer, M. A., Skali, H., Liu, J., Aguilar, D. A., Díaz, R., Dickstein, K., Gerstein, H. C., Køber, L., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1790 · Cited by 25
Efficacy of Drug Therapy in the Secondary Prevention of Cardiovascular Disease and Stroke
Fletcher, G. F., Bufalino, V. J., Costa, F., Goldstein, L. B., Jones, D., Smaha, L. A., Smith, S. C., & Stone, N. J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.02.001 · Cited by 27
Kao, D. P., Wagner, B. D., Robertson, A. D., Bristow, M. R., & Lowes, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048184 · Cited by 25
Self-citationClinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy
Zhang, Z., Meng, F., Hou, X., Qian, Z., Wang, Y., Qiu, Y., Jiang, Z.-Y., Du, A.-J., Qin, C., & Zou, J. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.04.004 · Cited by 24
Go, Y. Y., Allen, J. C., Chia, S. Y., Sim, L. L., Jaufeerally, F. R., Yap, J. J. L., Ching, C. K., Sim, D., Kwok, B. W. K., & Liew, R. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.119 · Cited by 24
Kristensen, S. L., Rørth, R., Jhund, P. S., Shen, L., Lee, M. M. Y., Petrie, M. C., Køber, L., & McMurray, J. J. V. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1201 · Cited by 24
Verdonschot, J. A. J., Ferreira, J. P., Pellicori, P., Rocca, H. B., Clark, A. L., Cosmi, F., Cuthbert, J. J., Girerd, N., Mariottoni, B., Petutschnigg, J., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01357-9 · Cited by 23
Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure
Andersson, C., Weeke, P., Pecini, R., Kjaergaard, J., Hassager, C., Køber, L., Torp-Pedersen, C., & On Behalf of the Echos Investigators (2010) · Scandinavian Cardiovascular Journal · doi:10.3109/14017430903312438 · Cited by 21
Metadata
- Authors
- Domanski, M., Krause-Steinrauf, H., Deedwania, P., Follmann, D., Ghali, J. K., Gilbert, E., Haffner, S., Katz, R., Lindenfeld, J., Lowes, B. D., Martin, W., McGrew, F., & Bristow, M. R.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- Fresno VA Medical Center (US)
- University of Utah (US)
- The University of Texas at San Antonio Health Science Center (US)
- George Washington University (US)
- University of Colorado Denver (US)
- St. Louis VA Medical Center (US)
- Baptist Memorial Hospital (US)
- Corresponding author
- Domanski, Michael
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 42
- Issue
- 5
- Pages
- 914-922
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2014986461
- Cited by
- 215
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 18 · 2019: 10 · 2018: 13 · 2017: 17 · 2016: 12 · 2015: 10 · 2014: 17 · 2013: 9 · 2012: 10
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- diabetes mellitus, advanced heart failure, beta-blocker therapy, bucindolol, ischemic cardiomyopathy, mortality, heart failure hospitalization, myocardial infarction, prognosis, comorbidities
- MeSH terms
- Adrenergic beta-Antagonists, Adult, Aged, Aged, 80 and over, Cause of Death, Female, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Prognosis, Propanolamines, Retrospective Studies, Risk Factors, Severity of Illness Index, Proportional Hazards Models, Survival Analysis, Heart Transplantation, Ventricular Function, Treatment Outcome, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
